Open AccessDivergent RET- and BRAF-Mediated Resistance to Osimertinib in EGFR-Mutant NSCLC: A Case Report
Author(s) -
Muneeb Rehman,
Chul Kim,
Joshua E. Reuss,
Lesli A. Kiedrowski,
Ravin J. Garg,
Stephen V. Liu
Publication year - 2021
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.21.00083
Subject(s) - osimertinib , mutant , cancer research , acquired resistance , oncology , medicine , biology , epidermal growth factor receptor , genetics , receptor , gene , cancer , erlotinib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom